Reported May 6, 2020 · Terminated
Ceftazidime for Injection USP and Dextrose for Injection USP, 2 g, 50 mL Duplex Container, RX only, B Braun Medical…
B. Braun Medical Inc.
High riskUsing this product could cause serious injury, illness or death — stop using it now.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: B. Braun Medical Inc · 2525 Mcgaw Ave · Irvine, CA · 92614-5841
Is this the product you have?
- Ceftazidime for Injection USP and Dextrose for Injection USP, 2 g, 50 mL Duplex Container, RX only, B Braun Medical Inc., Bethlehem, PA 18018-3524, NDC 0264-3145-11
- Lot codes and dates
Lot #: H8J812Exp. Date 31 JUL 2020
- Amount recalled
- 22,488 Duplex containers
Where it was sold
- Nationwide
Why it was recalled
Stop using this product now
Failed Stability Specifications: Out-of-Specification (OOS) results for High Molecular Weight Polymers.
Using this product could cause serious injury, illness or death — stop using it now.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new B. Braun Medical Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.